Informazioni sul prodotto
- 2,7,10,12-Tetraazatridecanoic acid
- 5-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-
- 5-thiazolylmethyl ester
- (3S,5S,6S,9S)-
- 2,4,7,12-Tetraazatridecan-13-oic acid
- 9-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-
- 5-thiazolylmethyl ester
- (5S,8S,9S,11S)- (9CI)
- 2,4,7,12-Tetraazatridecan-13-oic acid
- 9-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-
- Vedi altri sinonimi
- 5-thiazolylmethyl ester
- [5S-(5R*,8R*,9R*,11R*)]-
- Ritonavir Imp. N (EP)
Impurity Ritonavir EP Impurity N
Applications 4-Dehydroxy-5-Hydroxy Ritonavir (Ritonavir EP Impurity N) is an impurity of the selective HIV protease inhibitor Ritonavir (R535000). It is a COVID19-related research product.
References Kempf, D.J. et al.: J. Med. Chem., 41, 602 (1998); Mekapati, S.B. et al.: J. Enzyme Inhib., 16, 185 (2001);
Proprietà chimiche
Richiesta tecnica su: TR-D230645 4-Dehydroxy-5-hydroxy Ritonavir
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.